European Organization for Research and Treatment o... [Eur J Cancer. 2001]

Related citations

[Methodology and limitations of pre-clinical models for the development of anticarcinogenic chemotherapy combinations] [Bull Cancer. 1998]
[Methodology and limitations of pre-clinical models for the development of anticarcinogenic chemotherapy combinations]
Vassal G. Bull Cancer. 1998 Nov; 85(11):929-34.
Review In vivo/ex vivo and in situ assays used in cancer research: a brief review. [Toxicol Pathol. 2009]
Review In vivo/ex vivo and in situ assays used in cancer research: a brief review.
Teicher BA. Toxicol Pathol. 2009; 37(1):114-22. Epub 2008 Dec 19.
Review Medium-term protocols for in vivo evaluation of chemical modifiers of carcinogenesis. [Mem Inst Oswaldo Cruz. 1991]
Review Medium-term protocols for in vivo evaluation of chemical modifiers of carcinogenesis.
de Camargo JL. Mem Inst Oswaldo Cruz. 1991; 86 Suppl 2:47-50.
Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3. [Clin Cancer Res. 2008]
Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
Hu-Lowe DD, Zou HY, Grazzini ML, Hallin ME, Wickman GR, Amundson K, Chen JH, Rewolinski DA, Yamazaki S, Wu EY, et al. Clin Cancer Res. 2008 Nov 15; 14(22):7272-83.
Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors). [Cancer Lett. 2007]
Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
Hirokawa Y, Levitzki A, Lessene G, Baell J, Xiao Y, Zhu H, Maruta H. Cancer Lett. 2007 Jan 8; 245(1-2):242-51. Epub 2006 Mar 15.

See reviews... See all...

Cited by 2 PubMed Central articles

Lost in Translation: Obstacles to Translational Medicine. [J Transl Med. 2004]
Lost in Translation: Obstacles to Translational Medicine.
Mankoff SP, Brander C, Ferrone S, Marincola FM. J Transl Med. 2004 May 18; 2(1):14. Epub 2004 May 18.
Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice. [Br J Cancer. 2003]
Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice.
Leuraud P, Taillandier L, Aguirre-Cruz L, Medioni J, Crinière E, Marie Y, Dutrillaux AM, Kujas M, Duprez A, Delattre JY, et al. Br J Cancer. 2003 Dec 15; 89(12):2327-32.

All links from this record

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

European Organization for Research and Treatment of Cancer (EORTC) Laboratory Re...
European Organization for Research and Treatment of Cancer (EORTC) Laboratory Research Division workshop on the role of in vivo pre-clinical models in the development of contemporary cancer therapeutics, Verona, Italy, 3 February 2001.
Eur J Cancer. 2001 Nov ;37(16):1976-80.

PubMed
Taking dendritic cells into medicine.
Taking dendritic cells into medicine.
Nature. 2007 Sep 27 ;449(7161):419-26.

PubMed
Related Citations for PubMed (Select 19457253) (248)
PubMed
SCN4A-associated hypokalemic periodic paralysis merits a trial of acetazolamide.
SCN4A-associated hypokalemic periodic paralysis merits a trial of acetazolamide.
Neurology. 2004 Nov 23 ;63(10):1977.

PubMed
Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--...
Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--a case report.
J Transl Med. 2009 Jun 23 ;7:50.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

European Organization for Research and Treatment of Cancer (EORTC) Laboratory Research Division workshop on the role of in vivo pre-clinical models in the development of contemporary cancer therapeutics, Verona, Italy, 3 February 2001.

Publication Types, MeSH Terms, Substances

Publication Types:

MeSH Terms:

Substances:

LinkOut - more resources

Full Text Sources:

Libraries:

Supplemental Content

Related citations

Cited by 2 PubMed Central articles

All links from this record

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information